Despite being thought of as inert substances, excipients are essential forimproving drug permeability and solubility, which has a big impact onbioavailability and therapeutic results. Optimizing solubility and permeability iscrucial in biopharmaceutics, particularly for medications that fall into Classes IIand IV of the Biopharmaceutical Classification System (BCS) and are poorlysoluble in water and have low permeability. The mechanisms by whichexcipients affect drug permeability and solubility are examined in this review,with a focus on how they affect formulation development. To increase drugsolubility, excipients such lipid-based carriers, polymers, and surfactants havebeen used widely. By decreasing surface tension and improving drug particlewetting, surfactants, for instance, improve solubility and make it easier for drugsto dissolve in gastrointestinal (GI) fluids. Solid dispersions are produced byhydrophilic polymers such as polyethylene glycol (PEG) andpolyvinylpyrrolidone (PVP), which stabilize medications in an amorphous statethat is more soluble than crystalline forms. By increasing its dispersion in GIfluids, lipid-based formulations like liposomes and self-emulsifying drugdelivery systems (SEDDS) provide other ways to increase the solubility ofhydrophobic medications. Excipients are essential for boosting medicationpermeability in addition to improving solubility. Drug transport across intestinalbarriers is facilitated by penetration enhancers including bile salts, fatty acids,and surfactants, which alter the integrity of biological membranes. Theseexcipients function by promoting fluidity in membranes, facilitating tightjunctions, or blocking efflux transporters, such as P-glycoprotein, which activelyremove medications from cells. These excipients greatly enhance drugabsorption by removing permeability barriers, particularly for medications withlimited permeability in their native condition. Even while excipients havebenefits, using them might provide difficulties. Formulation development musttake into account safety issues, legal barriers, and the possibility of interactionsbetween excipients and active pharmaceutical ingredients (APIs). Furthermore,physiological variables including pH variations and GI tract enzyme activitymight cause excipient performance to vary, which could affect the uniformity ofmedication absorption. Excipients are essential to contemporary medicationformulation, especially when it comes to enhancing the permeability andsolubility of difficult drug candidates. New opportunities for improvingmedication absorption and bioavailability are constantly presented bydevelopments in excipient technology. Nonetheless, further investigation isrequired to tackle safety, stability, and regulatory issues, guaranteeing thatexcipients efficiently enhance drug delivery in biopharmaceutical applications.